Company Announcements

IFRS 17 session slides and reporting date updates

Source: RNS
RNS Number : 1943A
Beazley PLC
22 May 2023
 

 

 

 

 

Beazley plc

 

London, 22 May 2023

 

 

IFRS 17 session slides and updates to reporting dates

 

Beazley plc announces that the slides for analysts and institutional investors at 16:00 BST on Monday 22 May are now available on Beazley's website:

 

https://investor.relations.beazley.com/~/media/Files/B/Beazley-IR-V3/documents/presentations/2023/ifrs-17-analyst-briefing-22-may-2023.pdf

 

Key updates to reporting timeframes are as follows:

 

27 July 2023 - Half Year Trading Update including IFRS 17 comparatives

 

7 September 2023 - Interim Results

 

For further information please contact:

 

Beazley plc

Sarah Booth

 

+44 (0) 207 6747582

 

Note to editors:

Beazley plc (BEZ.L), is the parent company of specialist insurance businesses with operations in Europe, North America, Latin America and Asia. Beazley manages seven Lloyd's syndicates and, in 2022, underwrote gross premiums worldwide of $5,268.7 million. All Lloyd's syndicates are rated A by A.M. Best. 

 

Beazley's underwriters in the United States focus on writing a range of specialist insurance products. In the admitted market, coverage is provided by Beazley Insurance Company, Inc., an A.M. Best A rated carrier licensed in all 50 states. In the surplus lines market, coverage is provided by the Beazley syndicates at Lloyd's.

 

Beazley's European insurance company, Beazley Insurance dac, is regulated by the Central Bank of Ireland and is A rated by A.M. Best and A+ by Fitch.

 

Beazley is a market leader in many of its chosen lines, which include professional indemnity, cyber liability, property, marine, reinsurance, accident and life, and political risks and contingency business.

 

For more information please go to: www.beazley.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCATMLTMTBTMMJ